Skip to main content

Advertisement

SpringerLink
Log in

CANCER THERAPY

Molecular profiling in precision medicine oncology

  • News & Views
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Three innovative precision medicine studies show the utility of evidence beyond that from tumor DNA sequencing to guide therapy in patients with cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1: New concepts evaluated in the I-PREDICT, TARGET and WINTHER studies.

References

  1. Yates, L. R. Ann. Oncol. 29, 30–35 (2018).

    Article  CAS  Google Scholar 

  2. Le, D. T. New Engl. J. Med. 372, 2509–2520 (2015).

    Article  CAS  Google Scholar 

  3. Drilon, A. New Engl. J. Med. 378, 731–739 (2018).

    Article  CAS  Google Scholar 

  4. Rothwell, D. G. Nat. Med. https://doi.org/10.1038/s41591-019-0380-z (2019).

  5. Sicklick, J. K. Nat. Med. https://doi.org/10.1038/s41591-019-0407-5 (2019).

  6. Rodon, J. Nat. Med. https://doi.org/10.1038/s41591-019-0424-4 (2019).

  7. von Hoff, D. D. J. Clin. Oncol. 28, 4877–4883 (2010).

    Article  Google Scholar 

  8. Stockley, T. L. Genome Med. 8, 109 (2016).

    Article  Google Scholar 

  9. Le Tourneau, C. Lancet Oncol. 16, 1324–1334 (2015).

    Article  Google Scholar 

  10. Belin, L. Ann. Oncol. 28, 590–596 (2017).

    CAS  PubMed  Google Scholar 

  11. Massard, C. Cancer Disco. 7, 586–595 (2017).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Drug Development and Innovation (D3i), Institut Curie, Paris & Saint-Cloud, France

    Christophe Le Tourneau, Edith Borcoman & Maud Kamal

  2. INSERM U900 Research unit, Saint-Cloud, France

    Christophe Le Tourneau

  3. Paris-Saclay University, Paris, France

    Christophe Le Tourneau

Authors
  1. Christophe Le Tourneau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edith Borcoman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maud Kamal
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the writing of the manuscript.

Corresponding author

Correspondence to Christophe Le Tourneau.

Ethics declarations

Competing interests

C.L.T. has received consultant fees from Merck Serono, Merck & Co., Bristol-Myers Squibb, Amgen, Novartis, GlaxoSmithKline and Roche.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Le Tourneau, C., Borcoman, E. & Kamal, M. Molecular profiling in precision medicine oncology. Nat Med 25, 711–712 (2019). https://doi.org/10.1038/s41591-019-0442-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-019-0442-2

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation